Skip to main content

Faga Daniel's Form 4 filing

Anaptysbio, Inc (ANAB) · filed Mar 27, 2026

Accession no.
0001673528-26-000007
Filed
Mar 27, 2026
Trade date
Mar 25-27, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 11 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.09M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Faga DanielCIK 0001673528Director, Officer (President, CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 25, 2026Common StockAGrant or awardAcquired+34,300––513,644Direct
Mar 27, 2026Common StockSSaleDisposed−510$56.61−$28,871.1513,134Direct
Mar 27, 2026Common StockSSaleDisposed−2,570$57.91−$148,828.7510,564Direct
Mar 27, 2026Common StockSSaleDisposed−3,662$58.62−$214,666.44506,902Direct
Mar 27, 2026Common StockSSaleDisposed−490$59.62−$29,213.8506,412Direct
Mar 27, 2026Common StockSSaleDisposed−550$60.63−$33,346.5505,862Direct
Mar 27, 2026Common StockSSaleDisposed−1,012$62.15−$62,895.8504,850Direct
Mar 27, 2026Common StockSSaleDisposed−2,592$63.35−$164,203.2502,258Direct
Mar 27, 2026Common StockSSaleDisposed−3,155$64.19−$202,519.45499,103Direct
Mar 27, 2026Common StockSSaleDisposed−3,038$65.20−$198,077.6496,065Direct
Mar 27, 2026Common StockSSaleDisposed−100$65.99−$6,599495,965Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)